Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma - Slideshow (NASDAQ:KURA) 2026-04-21
Summary
2026-04-21. The following slide deck was published by Kura Oncology, Inc.
Description
2026-04-21. The following slide deck was published by Kura Oncology, Inc.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source